Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients
NCT04203095
·
clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST:
the level of plasma cfDNA CINs
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China